Home/Filings/4/0001209191-22-006492
4//SEC Filing

Gros David-Alexandre C 4

Accession 0001209191-22-006492

CIK 0001404281other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:38 PM ET

Size

5.7 KB

Accession

0001209191-22-006492

Insider Transaction Report

Form 4
Period: 2022-02-01
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-01+108,000108,000 total
    Exercise: $3.97Exp: 2032-02-01Common Stock (108,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase up to 108,000 shares of Common Stock, which option vests with respect to 27,000 shares on February 1, 2023, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending February 1, 2026.

Issuer

Eledon Pharmaceuticals, Inc.

CIK 0001404281

Entity typeother

Related Parties

1
  • filerCIK 0001644489

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:38 PM ET
Size
5.7 KB